A transaction-underwriting guide to specialty pharmacy M&A, including buyer demand, script volume, patient persistence, therapy and drug mix, PBM and payer access, limited-distribution drugs, accreditation, 340B relationships, DSCSA, hub services, revenue cycle, inventory, working capital, EBITDA quality, valuation, structure, integration, and seller proceeds.
A buyer-underwriting guide to specialty pharmacy valuation, including paid scripts, active patients, therapy and drug mix, payer and PBM access, manufacturer relationships, limited-distribution drugs, accreditation, 340B arrangements, reimbursement, gross margin, inventory, working capital, normalized EBITDA, valuation multiples, transaction structure, and seller proceeds.
A seller-focused guide to selling a specialty pharmacy, including exit planning, valuation preparation, script and patient evidence, payer and PBM access, manufacturer relationships, accreditation, inventory, working capital, buyer qualification, confidentiality, LOI comparison, diligence, transaction structure, closing, transition planning, and seller proceeds.